Translational Pathology Core Facility The Translational Pathology (Core) Laboratory (TPL) is designed to meet the needs of basic, clinical, and population scientists who require analysis of human tissues. TPL provides access to formalin-fixed, paraffin embedded tissues from UNC Hospitals, histopathology services, tissue and cell microarrays, morphological evaluation, morphology-based assays (immunohistochemistry, immunofluorescence, in-situ hybridization, and fluorescence in-situ hybridization), assay development &training, and digital imaging and image analysis for spatial quantification of molecular analytes in intact specimens. TPL is led by Drs. C Ryan Miller (Faculty Director), a leader in translational research and molecular analyses of tissues, and Nana Nikolaishvili-Feinberg (Facility Director), a researcher with experience in all morphological assays and digital image analyses. The LCCC has made significant investments in the TPL to expand services, to purchase forward-looking equipment, to increase capacity through additional staffing, and to develop informatics infrastructure to facilitate case identification, workflow improvements, and integration of digital images and quantitative image analysis data. The latter will allow integration of data from morphology-based assays with those from OMICS technologies. Core use expanded significantly in 2007-2009, in capacity and total service units performed. This year, 51 Pis from eight different LCCC research programs and 36 clinical trials utilized the Core. In 2009, total use was 29,975 service units (80% LCCC members). For 2010, the Center requests $175,126 for personnel and other expenses to support this Core, a 63% increase from 2009, to be allocated towards additional personnel and maintenance contract costs for both existing and newly acquired equipment. Access to and utilization of this core facility will promote the translation of basic science findings to human cancers and permit clinical investigators to perform innovative clinical trials using molecular correlates and endpoints. It will serve population scientists with molecular epidemiology studies on large numbers of samples that require morphological evaluation and assays. Future plans include acquisition of additional automated image analysis equipment and informatics integration with the Bioinformatics Core databases through the LCCC Data Warehouse.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-37
Application #
8392178
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
37
Fiscal Year
2013
Total Cost
$235,108
Indirect Cost
$72,662
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Ma, Shaohua; Paiboonrungruan, Chorlada; Yan, Tiansheng et al. (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434:164-172
Aung, Kyaw L; Fischer, Sandra E; Denroche, Robert E et al. (2018) Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res 24:1344-1354
Suh, Junghyun L; Watts, Brian; Stuckey, Jacob I et al. (2018) Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry 57:2140-2149
Brock, William J; Beaudoin, James J; Slizgi, Jason R et al. (2018) Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease. Int J Toxicol 37:144-154
Thomas, Nancy E; Edmiston, Sharon N; Tsai, Yihsuan S et al. (2018) Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. Am J Dermatopathol :
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Hall, Marissa G; Marteau, Theresa M; Sunstein, Cass R et al. (2018) Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med 41:398-405
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Wu, Bing; Zhang, Song; Guo, Zengli et al. (2018) RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs. Immunity 49:886-898.e5
Ding, Li; Bailey, Matthew H; Porta-Pardo, Eduard et al. (2018) Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell 173:305-320.e10

Showing the most recent 10 out of 1525 publications